Overview

A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the Knee

Status:
Completed

Trial end date:
2015-05-01

Target enrollment:

Participant gender:

Summary

To assess the safety and efficacy of LBSA0103 (BDDE cross-linked sodium hyaluronate gel) when it is administered for the second time 26 weeks after its first administration in patients with osteoarthritis of the knee. The Safety and efficacy of 26weeks after its first administration will be also evaluated.

Phase:

Phase 3

Details

Lead Sponsor:

LG Life Sciences

Treatments:

Hyaluronic Acid